NCT02408978View on ClinicalTrials.gov

Pilot Study of OXP005 to Assess Gastroduodenal Irritation

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Gastroduodenal Erosions
Interventions
DRUG

OXP005

DRUG

Naproxen

Trial Locations (1)

Unknown

Quotient Clinical Ltd, Nottingham

Sponsors
All Listed Sponsors
lead

Oxford Pharmascience Ltd

INDUSTRY